Vident Investment Advisory, LLC Novavax Inc Transaction History

Vident Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $274,457 - $562,454	-3,936 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $58,668 - $95,034	-436 Reduced 9.97%	3,936 $563,000
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $306,349 - $466,209	-1,723 Reduced 28.27%	4,372 $906,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $263,054 - $560,174	2,174 Added 55.45%	6,095 $1.29 Million
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $442,994 - $1.25 Million	3,921 New	3,921 $711,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.